Prosecution Insights
Last updated: November 04, 2026

The United States Department of Veterans Affairs

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

The United States Department of Veterans Affairs holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area, currently featuring 1 pending office action. This matter is assigned to 1 distinct examiner and 1 distinct art unit, showing a concentrated prosecution strategy. For a portfolio of this type, the current activity is limited to a single point of interaction within the patent office's Biotechnology & Pharmaceuticals division.

The busiest examiner for this portfolio is WEIDNER, ADAM M, who is overseeing 1 busiest examiner pending action. This single action constitutes the total volume of 1 pending office action for the company. Consequently, the examiner's specific interpretation of the claims will be the decisive factor in the immediate success of the portfolio. The relationship between the examiner and the pending workload simplifies the management of the company's active matters.

The presence of 1 distinct art unit and 1 distinct examiner means there is no variation in the examination environment for this portfolio. While this focus allows for a clear prosecution path for the 1 pending office action, it also means the company is not currently testing its technology across different art units. The strategy is entirely dependent on the resolution of this single active case in the Biotechnology & Pharmaceuticals field.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAUSCH, SARAE L 1 29.6% +45.2%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17609985 METHODS CONCERNING ONGOING TREATMENT FOR CANCER BAUSCH, SARAE L —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17609985 METHODS CONCERNING ONGOING TREATMENT FOR CANCER BAUSCH, SARAE L —

Top Art Units

Art UnitApps
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17609985 METHODS CONCERNING ONGOING TREATMENT FOR CANCER BAUSCH, SARAE L 1699 §101§102§103§112 Final Rejection — Pending Nov 09, 2021

Managing The United States Department of Veterans Affairs's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does The United States Department of Veterans Affairs have?

The United States Department of Veterans Affairs has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most The United States Department of Veterans Affairs applications?

Sarae L Bausch has the most, with 1 of The United States Department of Veterans Affairs's pending office actions.

What technology area are The United States Department of Veterans Affairs's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month